Loading song details...
Prof Siefker Radtke On The EV 103 Trial In Bladder Cancer
No description available.
MP3 Download
Video Download
Related Songs
0:45
Prof Siefker Radtke On The EV 103 Trial In Bladder Cancer
1:19
Dr Siefker Radtke On Advancements In Small Cell Urothelial Cancer
0:53
Dr Siefker Radtke On FDA Approval Of Durvalumab In Bladder Cancer
1:51
Dr Siefker Radtke On The Treatment Of FGFR Altered Bladder Cancer
1:54
Dr Siefker Radtke On The Phase II Study Of Erdafitinib In Patients With Urothelial Carcinoma
1:18
Arlene Siefker Radtke MD Discusses Some Of The Antibody Drug Conjugates Currently In Development
4:42
Arlene Siefker Radtke MD Regarding The Development Of Erdafitinib In Bladder Cancer
2:44
Arlene Siefker Radtke MD On The Management Of Treatment Emergent AEs Use FGFR Inhibitors
1:47
Dr Siefker Radtke On PD L1 As A Biomarker In Bladder Cancer
0:55
Dr Siefker Radtke On FDA Approval Of Frontline Atezolizumab In Bladder Cancer
1:08
Dr Siefker Radtke On Bempegaldesleukin Plus Nivolumab In Urothelial Carcinoma
0:38
Dr Siefker Radtke On FDA Approval Of Avelumab In Bladder Cancer
2:00
Arlene Siefker Radtke MD Regarding The EV 201 Cohort 2 Study Clinical Implications For Patients
11:48
Update On Erdafitinib A Treatment For Metastatic Urothelial Cancer With Dr Siefker Radtke
1:59
Arlene Siefker Radtke MD On How New Data Will Impact Treatment Of Neoadjuvant Bladder Cancer
0:57
Dr Siefker Radtke On Next Steps With Erdafitinib In Bladder Cancer
1:30
Arlene Siefker Radtke MD Shares The Role Of Selecting Mutations Vs Amplification For UC Treatment
1:08
Dr Arlene O Siefker Radtke On Neoadjuvant Chemotherapy Plus Surgery In Bladder Cancer
1:29
Arlene Siefker Radtke ASCO GU Highlights
0:53